Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60

被引:44
|
作者
Parissi, V
Calmels, C
De Soultrait, VR
Caumont, A
Fournier, M
Chaignepain, S
Litvak, S
机构
[1] Univ Bordeaux 2, REGER, CNRS, UMR 5097, F-33076 Bordeaux, France
[2] Hop Pellegrin, Virol Lab, F-33076 Bordeaux, France
[3] IBGC, CNRS, Bordeaux, France
[4] IFR66 Pathol Infect, Bordeaux, France
关键词
D O I
10.1128/JVI.75.23.11344-11353.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Integration of human immunodeficiency virus type 1 (HIV-1) proviral DNA in the nuclear genome is catalyzed by the retroviral integrase (IN). In addition to IN, viral and cellular proteins associated in the high-molecular-weight preintegration complex have been suggested to be involved in this process. In an attempt to define host factors interacting with IN, we used an in vitro system to identify cellular proteins in interaction with HIV-1 IN. The yeast Saccharomyces cerevisiae was chosen since (i) its complete sequence has been established and the primary structure of all the putative proteins from this eucaryote has been deduced, (ii) there is a significant degree of homology between human and yeast proteins, and (iii) we have previously shown that the expression of HIV-1 IN in yeast induces a lethal phenotype. Strong evidences suggest that this lethality is linked to IN activity in infected human cells where integration requires the cleavage of genomic DNA. Using IN-affinity chromatography we identified four yeast proteins interacting with HIV-1 IN, including the yeast chaperonin yHSP60, which is the counterpart of human hHSP60. Yeast lethality induced by HIV-1 IN was abolished when a mutated HSP60 was coexpressed, therefore suggesting that both proteins interact in vivo. Besides interacting with HIV-1 IN, the hHSP60 was able to stimulate the in vitro processing and joining activities of IN and protected this enzyme from thermal denaturation. In addition, the functional human HSP60-HSP10 complex in the presence of ATP was able to recognize the HIV-1 IN as a substrate.
引用
收藏
页码:11344 / 11353
页数:10
相关论文
共 50 条
  • [41] INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE
    FESEN, MR
    KOHN, KW
    LETEURTRE, F
    POMMIER, Y
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) : 2399 - 2403
  • [42] THE HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE PROTEIN
    VINK, C
    PLASTERK, RHA
    TRENDS IN GENETICS, 1993, 9 (12) : 433 - 437
  • [43] Human immunodeficiency virus type 1 Vpr: functions and molecular interactions
    Romani, Bizhan
    Engelbrecht, Susan
    JOURNAL OF GENERAL VIROLOGY, 2009, 90 : 1795 - 1805
  • [44] Interactions between Human Immunodeficiency Virus Type 1 and Polymorphonuclear Neutrophils
    Casulli, Sarah
    Elbim, Carole
    JOURNAL OF INNATE IMMUNITY, 2014, 6 (01) : 13 - 20
  • [45] Immunological efficacy of hsp60 peptide DiaPep277 therapy in human type 1 diabetes
    Roep, Bart
    CLINICAL IMMUNOLOGY, 2007, 123 : S7 - S8
  • [46] Integrase-LexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integration
    Holmes-Son, ML
    Chow, SA
    JOURNAL OF VIROLOGY, 2000, 74 (24) : 11548 - 11556
  • [47] 2-mercaptobenzenesulphonamides as novel inhibitors of human immunodeficiency virus type 1 integrase and replication
    Neamati, N
    Mazumder, A
    Sunder, S
    Owen, JM
    Schultz, RJ
    Pommier, Y
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (06): : 485 - 495
  • [48] INTEGRASE MUTANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH A SPECIFIC DEFECT IN INTEGRATION
    TADDEO, B
    HASELTINE, WA
    FARNET, CM
    JOURNAL OF VIROLOGY, 1994, 68 (12) : 8401 - 8405
  • [49] Pharmacovirological Impact of an Integrase Inhibitor on Human Immunodeficiency Virus Type 1 cDNA Species In Vivo
    Goffinet, Christine
    Allespach, Ina
    Oberbremer, Lena
    Golden, Pamela L.
    Foster, Scott A.
    Johns, Brian A.
    Weatherhead, Jason G.
    Novick, Steven J.
    Chiswell, Karen E.
    Garvey, Edward P.
    Keppler, Oliver T.
    JOURNAL OF VIROLOGY, 2009, 83 (15) : 7706 - 7717
  • [50] Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H
    Marchand, Christophe
    Beutler, John A.
    Wamiru, Antony
    Budihas, Scott
    Moellmann, Ute
    Heinisch, Lothar
    Mellors, John W.
    Le Grice, Stuart F.
    Pommier, Yves
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) : 361 - 364